Oncology & Hematology Coding Alert

Reader Questions:

Investigate Reason for Tamoxifen

Question: If a patient completes chemo treatment for breast cancer but now takes Tamoxifen, what diagnosis code should I use - V10.3 or 174.9?

Texas Subscriber Answer: This common treatment is tricky for lots of coders. If the oncologist orders the Tamoxifen for prevention - as your example suggests - you may code "history of." But if this patient needs the drug to treat remaining cancer cells, you should report the ICD-9 code for breast cancer.
 
The American Hospital Association's official coding guidelines say that once you have eradicated a malignancy and it requires no further treatment, you should use a category V10 code. In this case, that would be V10.3 (Personal history of malignant neoplasm; breast). You can see the rules at www.cdc.gov/nchs/data/icd9/icdguide.pdf.
 
Physicians also prescribe Tamoxifen as a breast cancer treatment because the drug slows the growth of cancer cells. If your documentation indicates the presence of cancer cells, you should report 174.9 (Malignant neoplasm of breast [female], unspecified), or preferably, a more specific code from the 174.x range (Malignant neoplasm of female breast).
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All